関与物質
| 役割 | 名称 | HCID | 仕込み量 |
|---|
| 反応物 | 4-Methylquinoline | HCID 10285 | — |
| 反応物 | Tert-butyl 3-iodoazetidine-1-carboxylate | HCID 11000522 | — |
| 試薬 | Hydrogen Peroxide | HCID 784 | — |
| 試薬 | Sulfuric Acid | HCID 1118 | — |
| 触媒 | CID 516917 | HCID 516917 | — |
| 溶媒 | Dimethyl Sulfoxide | HCID 679 | — |
| 溶媒 | Water | HCID 962 | — |
| 生成物 | Tert-butyl 3-(4-methylquinolin-2-yl)azetidine-1-carboxylate | HCID 44239816 | 30% |
反応手順
H2O2 (30% in H2O; 0.31 mL, 3.0 mmol) was added to a stirred solution of lepidine 1a (132 μL, 1.0 mmol), concentrated H2SO4 (53 μL, 1.0 mmol), 1-Boc-3-(iodo)azetidine (849 mg, 3.0 mmol) and iron(II) sulfate heptahydrate (80 mg, 0.3 mmol) in DMSO (10 mL) at room temperature. After 1-2 min a further portion of iron(II) sulfate heptahydrate (80 mg, 0.3 mmol) was added and the mixture was stirred at room temperature for 30 min. Further H2O2 (0.31 mL, 3.0 mmol) and iron(II) sulfate heptahydrate (80 mg, 0.3 mmol) was added, and the mixture was stirred for 60 min, then poured into a 0.2 M solution of NaOH (30 mL) and Et2O (50 - 12 -mL). The aqueous and organic layers were partitioned and the organic layer was washed with H2O (1 x 30 mL) and brine (1 x 30 mL), then dried (MgSO4), filtered and the solvent removed under vacuum to leave a crude oil. The oil was purified by preparative thin-layer chromatography using EtOAc / hexanes (3:7) as eluent to give the desired product 3a (90 mg, 30%) as a solid and a 9:1 mixture of lepidine 1aand desired product 3a (58 mg).
情報源と証拠
| DOI | 10.1021/jo9010624 |
|---|
| 出典データセット | Minisci dataset from Roche |
|---|
| ORD ID | ord-b0452385aefe4a3e9a6b9674ebddeaf6 |
|---|
| 出典メモ | Minisci dataset from Roche |
|---|